TONIX PHARMACEUTICALS HOLDING CORP
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 91.94B | ||||||
| 38.74B | ||||||
| 32.82B | ||||||
| 26.66B | ||||||
| 15.32B |
